---  
layout: startup_page  
title: "Firefly Bio"  
id: "fireflybiologics.com"  
permalink: "/fireflybiofireflybiologics.com02152024/"  
website: "https://fireflybiologics.com/"  
funding_round: "Series A"  
funding_amount: "$94M"  
investors: "Versant Ventures, MPM BioImpact, Decheng Capital, Eli Lilly & Company"  
about: "Firefly Bio develops a novel platform to treat cancer using degrader antibody conjugates (DACs). Their proprietary Firelink linker technology combines the strengths of antibody drug conjugates (ADCs) and protein degraders, overcoming limitations of each to create a new class of highly specific and effective cancer therapeutics. This platform enables DACs at scale, vastly expanding the number of payloads for ADCs."  
markets: "Biotechnology, Oncology, Immunology, Medical, Drug Discovery, HealthTech, Life Sciences"  
hq: "South San Francisco, California, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/firefly-biologics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/firefly-bio"  
pitchbook: "https://pitchbook.com/profiles/company/515966-41"  

date_display: "15-Feb-2024"  
date: "2024-02-15"

# SEO Optimization  
meta_title: "Firefly Bio - Series A Funding ($94M)"  
meta_description: "Firefly Bio, Firefly Bio develops a novel platform to treat cancer using degrader antibody conjugates (DACs). Their proprietary Firelink linker technology combines..."  
meta_keywords: "Firefly Bio, Biotechnology, Oncology, Immunology, Medical, Drug Discovery, HealthTech, Life Sciences, Series A funding"  
canonical_url: "https://startup.projectstartups.com/fireflybiofireflybiologics.com02152024/"  
---